| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MSCI Inc. | Chairman and CEO, Director | Common Stock | 1,493,847 | $776,800,440 | $520.00 | 17 Feb 2026 | Direct |
| MSCI Inc. | Chairman and CEO, Director | Common Stock | 335,069 | $196,672,100 | $586.96 | 13 Feb 2026 | By Fernandez 2007 Children's Trust |
| MSCI Inc. | Chairman and CEO, Director | Common Stock | 309,821 | $181,852,534 | $586.96 | 13 Feb 2026 | By Henry Fernandez 2024 MSCI Annuity Trust |
| MSCI Inc. | Chairman and CEO, Director | Premium option to purchase common stock | 44,920 | $26,366,243 | $586.96 | 13 Feb 2026 | Direct |
| MSCI Inc. | Chairman and CEO, Director | Option to purchase common stock | 42,193 | $24,765,603 | $586.96 | 13 Feb 2026 | Direct |
| MSCI Inc. | Chairman and CEO, Director | Common Stock | 15,400 | $9,039,184 | $586.96 | 13 Feb 2026 | By Daughter |
| MSCI Inc. | Chairman and CEO, Director | Common Stock | 15,400 | $9,039,184 | $586.96 | 13 Feb 2026 | By Son |
| Royalty Pharma plc | Director | Class A Ordinary Shares | 65,324 | $2,301,985 | $35.24 | 30 Jun 2025 | Direct |
| Royalty Pharma plc | Director | Class A Ordinary Shares | 58,200 | $1,888,590 | $32.45 | 30 Jun 2025 | By Fernandez 2007 Children's Trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MSCI | MSCI Inc. | 13 Feb 2026 | 4 | +$3,560,239 | 4 | Chairman and CEO, Director | 17 Feb 2026, 18:02 |
| MSCI | MSCI Inc. | 26 Jan 2026 | 1 | $0 | 4 | Chairman and CEO, Director | 28 Jan 2026, 16:02 |
| MSCI | MSCI Inc. | 05 Dec 2025 | 19 | +$6,701,732 | 4 | Chairman and CEO, Director | 09 Dec 2025, 06:38 |
| MSCI | MSCI Inc. | 24 Jul 2025 | 5 | +$6,731,599 | 4 | Chairman and CEO, Director | 28 Jul 2025, 16:30 |
| RPRX | Royalty Pharma plc | 30 Jun 2025 | 1 | +$37,495 | 4 | Director | 30 Jun 2025, 17:06 |
| RPRX | Royalty Pharma plc | 13 May 2025 | 1 | $0 | 4 | Director | 14 May 2025, 17:08 |
| RPRX | Royalty Pharma plc | 31 Mar 2025 | 1 | +$37,500 | 4 | Director | 01 Apr 2025, 17:45 |
| MSCI | MSCI Inc. | 24 Feb 2025 | 3 | +$3,044,902 | 4 | Chairman and CEO, Director | 25 Feb 2025, 06:27 |
| MSCI | MSCI Inc. | 06 Feb 2025 | 2 | -$18,963,267 | 4 | Chairman and CEO, Director | 10 Feb 2025, 16:01 |
| MSCI | MSCI Inc. | 31 Jan 2025 | 3 | $0 | 4 | Chairman and CEO, Director | 04 Feb 2025, 16:01 |
| MSCI | MSCI Inc. | 27 Jan 2025 | 1 | $0 | 4 | Chairman and CEO, Director | 29 Jan 2025, 16:07 |
| RPRX | Royalty Pharma plc | 31 Dec 2024 | 1 | +$37,487 | 4 | Director | 02 Jan 2025, 16:28 |
| MSCI | MSCI Inc. | 05 Dec 2024 | 3 | +$1,777,119 | 4 | Chairman and CEO, Director | 09 Dec 2024, 06:55 |
| RPRX | Royalty Pharma plc | 30 Sep 2024 | 1 | +$37,475 | 4 | Director | 30 Sep 2024, 17:07 |
| RPRX | Royalty Pharma plc | 28 Jun 2024 | 1 | +$37,493 | 4 | Director | 28 Jun 2024, 17:12 |
| RPRX | Royalty Pharma plc | 07 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:13 |
| MSCI | MSCI Inc. | 25 Apr 2024 | 15 | +$6,056,955 | 4 | Chairman and CEO, Director | 26 Apr 2024, 09:19 |
| RPRX | Royalty Pharma plc | 28 Mar 2024 | 1 | +$37,483 | 4 | Director | 02 Apr 2024, 17:30 |
| MSCI | MSCI Inc. | 05 Feb 2024 | 4 | -$29,461,778 | 4 | Chairman and CEO, Director | 07 Feb 2024, 20:09 |
| RPRX | Royalty Pharma plc | 29 Dec 2023 | 1 | +$37,493 | 4 | Director | 29 Dec 2023, 17:14 |
| RPRX | Royalty Pharma plc | 29 Sep 2023 | 1 | +$37,475 | 4 | Director | 03 Oct 2023, 16:25 |
| RPRX | Royalty Pharma plc | 30 Jun 2023 | 1 | +$37,481 | 4 | Director | 30 Jun 2023, 09:15 |
| RPRX | Royalty Pharma plc | 23 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:07 |
| RPRX | Royalty Pharma plc | 31 Mar 2023 | 1 | +$37,478 | 4 | Director | 31 Mar 2023, 16:40 |
| MSCI | MSCI Inc. | 08 Feb 2023 | 2 | -$8,768,947 | 4 | Chairman and CEO, Director | 10 Feb 2023, 15:33 |
| RPRX | Royalty Pharma plc | 30 Dec 2022 | 1 | +$37,495 | 4 | Director | 03 Jan 2023, 16:11 |
| RPRX | Royalty Pharma plc | 30 Sep 2022 | 1 | +$37,490 | 4 | Director | 30 Sep 2022, 16:25 |
| RPRX | Royalty Pharma plc | 30 Jun 2022 | 1 | +$37,493 | 4 | Director | 30 Jun 2022, 06:51 |
| RPRX | Royalty Pharma plc | 24 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:49 |
| RPRX | Royalty Pharma plc | 31 Mar 2022 | 1 | +$37,471 | 4 | Director | 01 Apr 2022, 18:29 |
| RPRX | Royalty Pharma plc | 24 Feb 2022 | 1 | +$1,218,373 | 4 | Director | 25 Feb 2022, 18:21 |
| MSCI | MSCI Inc. | 07 Feb 2022 | 6 | -$23,372,107 | 4 | Chairman and CEO, Director | 09 Feb 2022, 15:15 |
| RPRX | Royalty Pharma plc | 31 Dec 2021 | 1 | +$37,463 | 4 | Director | 03 Jan 2022, 16:35 |
| RPRX | Royalty Pharma plc | 30 Sep 2021 | 1 | +$37,499 | 4 | Director | 30 Sep 2021, 15:17 |
| RPRX | Royalty Pharma plc | 30 Jun 2021 | 1 | +$37,489 | 4 | Director | 30 Jun 2021, 17:50 |
| RPRX | Royalty Pharma plc | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 20:28 |